These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
458 related articles for article (PubMed ID: 31881361)
21. NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease. Syn WK; Agboola KM; Swiderska M; Michelotti GA; Liaskou E; Pang H; Xie G; Philips G; Chan IS; Karaca GF; Pereira Tde A; Chen Y; Mi Z; Kuo PC; Choi SS; Guy CD; Abdelmalek MF; Diehl AM Gut; 2012 Sep; 61(9):1323-9. PubMed ID: 22427237 [TBL] [Abstract][Full Text] [Related]
22. Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model. Hayashida M; Hashimoto K; Ishikawa T; Miyamoto Y Int J Exp Pathol; 2019 Apr; 100(2):72-82. PubMed ID: 30887659 [TBL] [Abstract][Full Text] [Related]
23. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice. Takatani N; Kono Y; Beppu F; Okamatsu-Ogura Y; Yamano Y; Miyashita K; Hosokawa M Biochem Biophys Res Commun; 2020 Jul; 528(2):305-310. PubMed ID: 32475638 [TBL] [Abstract][Full Text] [Related]
24. CXC Motif Ligand 16 Promotes Nonalcoholic Fatty Liver Disease Progression via Hepatocyte-Stellate Cell Crosstalk. Jiang L; Yang M; Li X; Wang Y; Zhou G; Zhao J J Clin Endocrinol Metab; 2018 Nov; 103(11):3974-3985. PubMed ID: 30053055 [TBL] [Abstract][Full Text] [Related]
25. Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis. Syn WK; Choi SS; Liaskou E; Karaca GF; Agboola KM; Oo YH; Mi Z; Pereira TA; Zdanowicz M; Malladi P; Chen Y; Moylan C; Jung Y; Bhattacharya SD; Teaberry V; Omenetti A; Abdelmalek MF; Guy CD; Adams DH; Kuo PC; Michelotti GA; Whitington PF; Diehl AM Hepatology; 2011 Jan; 53(1):106-15. PubMed ID: 20967826 [TBL] [Abstract][Full Text] [Related]
26. Novel Interplay Between Sonic Hedgehog and Transforming Growth Factor-β1 in Human Nonalcoholic Steatohepatitis. Zhou X; Wang P; Ma Z; Li M; Teng X; Sun L; Wan G; Li Y; Guo L; Liu H Appl Immunohistochem Mol Morphol; 2020 Feb; 28(2):154-160. PubMed ID: 32044884 [TBL] [Abstract][Full Text] [Related]
27. CPEB4 Increases Expression of PFKFB3 to Induce Glycolysis and Activate Mouse and Human Hepatic Stellate Cells, Promoting Liver Fibrosis. Mejias M; Gallego J; Naranjo-Suarez S; Ramirez M; Pell N; Manzano A; Suñer C; Bartrons R; Mendez R; Fernandez M Gastroenterology; 2020 Jul; 159(1):273-288. PubMed ID: 32169429 [TBL] [Abstract][Full Text] [Related]
34. Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice. Kim KH; Kim SH; Han DH; Jo YS; Lee YH; Lee MS Sci Rep; 2018 May; 8(1):6789. PubMed ID: 29717162 [TBL] [Abstract][Full Text] [Related]
35. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis. Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624 [TBL] [Abstract][Full Text] [Related]
36. Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis. An P; Wei LL; Zhao S; Sverdlov DY; Vaid KA; Miyamoto M; Kuramitsu K; Lai M; Popov YV Nat Commun; 2020 May; 11(1):2362. PubMed ID: 32398673 [TBL] [Abstract][Full Text] [Related]
37. Activin-A causes Hepatic stellate cell activation via the induction of TNFα and TGFβ in Kupffer cells. Kiagiadaki F; Kampa M; Voumvouraki A; Castanas E; Kouroumalis E; Notas G Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):891-899. PubMed ID: 29287776 [TBL] [Abstract][Full Text] [Related]
38. Acetylcholine induces fibrogenic effects via M2/M3 acetylcholine receptors in non-alcoholic steatohepatitis and in primary human hepatic stellate cells. Morgan ML; Sigala B; Soeda J; Cordero P; Nguyen V; McKee C; Mouraliderane A; Vinciguerra M; Oben JA J Gastroenterol Hepatol; 2016 Feb; 31(2):475-83. PubMed ID: 26270240 [TBL] [Abstract][Full Text] [Related]
39. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice. Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675 [TBL] [Abstract][Full Text] [Related]